ARWR- Arrowhead Pharmaceuticals, Inc.

Name: Arrowhead Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 36 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Anzalone Christopher Richard	3.79M	$311.00M	-
COO	O'Brien Patrick	473.3K	$38.81M	-
Other	Hamilton James C	227.0K	$18.61M	-
CFO	Apel Daniel Joseph	162.9K	$13.36M	-
Dir	Perry Michael S	123.1K	$10.09M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 11, 2022	Anzalone Christopher Richard60	Chief Executive Officer	Sale+OE	146,388	$51.91	$7,598,864.47	-0.9%	-40.2%	-34.6%
Jan 5, 2022	Myszkowski Kenneth Allen68	Chief Financial Officer	Sell	40,000	$61.70	$2,467,940.96	-2.1%	-19.6%	-38.4%
Jan 5, 2022	O'Brien Patrick76	General Counsel	Sell	32,500	$61.72	$2,005,875.26	-1.8%	-19.6%	-38.4%
Jan 5, 2022	Hamilton James C72	Senior Vice President	Sell	25,625	$64.57	$1,654,591.22	-1.6%	-19.6%	-38.4%
Jan 3, 2022	De Backer Marianne65	Director	Sell	4,500	$64.71	$291,176.84	-7.8%	-27.7%	-45.0%
Jan 3, 2022	Perry Michael S55	Director	Sell	4,500	$64.71	$291,192.40	-1.7%	-27.7%	-45.0%
Jan 3, 2022	Waddill William D.50	Director	Sell	4,500	$64.72	$291,244.28	-5.3%	-27.7%	-45.0%
Jan 3, 2022	Olukotun Adeoye Y52	Director	Sell	4,050	$64.75	$262,233.04	-19.0%	-27.7%	-45.0%
Dec 28, 2021	Ferrari Mauro71	Director	Sell	3,400	$66.82	$227,188.00	-8.5%	-32.2%	-43.1%
Dec 28, 2021	Given Douglas B66	Director	Buy	655	$66.37	$43,472.35	+0.6%	-32.2%	-43.1%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC